Johnson & Johnson’s Joaquin Duato became the best-paid CEO among the 12 biggest pharma companies in his second year on the job. With total compensation of $28.4m in 2023, more than double the $13.1m he received in 2022, he was back in the range of compensation enjoyed by his predecessor Alex Gorsky, who received $26.7m in 2021 and $29.6m in 2020. J&J has now been the big pharma company with the highest-remunerated CEO for four of the past three years.
Key Takeaways
-
Average CEO compensation among the top 12 pharma companies rose by 9.2% to $18.7m in 2023.
Duato, who took the helm at J&J in January 2022, oversaw the divestment of the company’s Kenvue Inc. consumer...